Get the Facts on Macular Degeneration

Macular degeneration is the leading cause of vision loss in people over age 60. In advanced stages, it can cause permanent vision loss.


Half of those impacted by macular degeneration may not even know it because there are often no noticeable symptoms in early stages.


Macular Degeneration Research, a program of BrightFocus Foundation, funds the most promising science and provides expert information on this devastating disease.


Together, we will find a cure.

Dr. Reilly Answers Your Macular Degeneration Questions

Headshot of Gayatri Reilly.

What is macular degeneration, what forms can it take, and how does it affect your eyes? Dr. Gayatri Reilly, a retina specialist and vitreoretinal surgeon at Retina Group of Washington, answered these questions and more in a BrightFocus Chat. 


A macula with geographic atrophy.

What is Geographic Atrophy?

Geographic atrophy is an advanced and severe form of dry macular degeneration that causes around 20% of legal blindness in North America. If you have already been diagnosed with dry macular degeneration, ask your doctor how often you need to be monitored for potential progression to geographic atrophy. The first treatment for geographic atrophy was approved in February 2023; there are several other promising treatments in clinical trials. BrightFocus is funding innovative research into new drugs and ways to manage and treat this complex form of AMD.

Don't miss out.

Female scientist in a lab holding test tubes.

Receive macular degeneration breakthrough news, research updates, and inspiring stories.

Senior couple embracing one another while sitting in a field with a background of fall trees.

Receive a Free Brochure

Download your free Understanding Macular Degeneration brochure, which includes important information about risk factors, questions to ask your doctor, and more. 


Macular Degeneration Research Program

Young woman undergoing eye examination.

BrightFocus Foundation is driving innovative research around the world to end macular degeneration. Our Macular Degeneration Research program takes a multi-pronged approach by funding bold research with the most promise of finding a cure.